Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

90.29
Delayed Data
As of Jan 14
 +2.13 / +2.42%
Today’s Change
71.59
Today|||52-Week Range
92.17
+2.20%
Year-to-Date
No recent news for Biomarin Pharmaceutical Inc.

Today’s Trading

Previous close88.16
Today’s open87.62
Day’s range86.40 - 90.30
Volume55,926
Average volume (3 months)1,415,265
Market cap$16.6B
Data as of 4:00pm ET, 01/14/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-107.84%
Earnings growth (next 5 years)+51.10%
Revenue growth (last year)+9.25%
P/E ratio1,003.2
Price/Sales9.12
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-7.03-1.77%
EXASExact Sciences Corp+3.11+4.12%
----
----
Data as of 4:01pm ET, 01/14/2022

Financials

Next reporting dateFebruary 24, 2022
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.8B
Annual profit (last year)$859.1M
Net profit margin46.63%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Rafael, California

Forecasts